{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"therapy-related-acute-myeloid-leukemia-and-myelodysplastic","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001)","mondoId":"MONDO:0019457","node":{"canonicalSlug":"therapy-related-acute-myeloid-leukemia-and-myelodysplastic","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"therapy related acute myeloid leukemia and myelodysplastic syndrome","paragraphs":["An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001)"],"scope":"exact","source":"MONDO","upstream":"NCIT:C25765","url":"https://monarchinitiative.org/MONDO:0019457"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"acute myeloid leukemia","mondoId":"MONDO:0018874","slug":"cytogenetically-normal-acute-myeloid-leukemia"},{"kind":"child","label":"acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent","mondoId":"MONDO:0015164","slug":"acute-myeloid-leukemia-and-myelodysplastic-syndromes-related-to-alkylating-agent"},{"kind":"child","label":"acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor","mondoId":"MONDO:0015165","slug":"acute-myeloid-leukemia-and-myelodysplastic-syndromes-related-to-topoisomerase-type-2-inhibitor"},{"kind":"child","label":"acute myeloid leukemia and myelodysplastic syndromes related to radiation","mondoId":"MONDO:0015608","slug":"acute-myeloid-leukemia-and-myelodysplastic-syndromes-related-to-radiation"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/12762"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019457\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C25765</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001)</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019457\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"therapy-related-acute-myeloid-leukemia-and-myelodysplastic","sourceDocuments":[{"name":"MONDO: therapy related acute myeloid leukemia and myelodysplastic syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019457"}],"sourceNote":"","synonyms":["Secondary Acute granulocytic Leukaemia","Secondary Acute granulocytic Leukemia","Secondary Acute myeloblastic Leukaemia","Secondary Acute myeloblastic Leukemia","Secondary Acute myelocytic Leukaemia","Secondary Acute myelocytic Leukemia","Secondary Acute myelogenous Leukaemia","Secondary Acute myelogenous Leukemia","secondary acute myeloid leukaemia","Secondary Acute myeloid Leukaemia (AML)","secondary acute myeloid leukemia","Secondary Acute myeloid Leukemia (AML)","Secondary AGL","secondary AML","therapy-related AML and myelodysplastic syndrome"],"takeawayHtml":"","title":"therapy related acute myeloid leukemia and myelodysplastic syndrome"},"schemaVersion":1}
